Structure and function of epigen, the last EGFR ligand

Seminars in Cell and Developmental Biology

Volumn 28, Issue , 2014, Pages 57-61

  Schneider, Marlon R ^a   Yarden, Yosef ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cancer; EGFR; Epigen; ERBB family; Gene knockout

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGEN; LIGAND; MESSENGER RNA; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR;

CHROMOSOMAL LOCALIZATION; EXPRESSED SEQUENCE TAG; GENE OVEREXPRESSION; GENE STRUCTURE; KNOCKOUT MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; TRANSGENIC MOUSE; ANIMAL; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EPIDERMAL GROWTH FACTOR; EPIGEN; GENE KNOCKOUT TECHNIQUES; HUMANS; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84901236498     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.12.011     Document Type: Review

References (45)

1. Cohen S., Levi-Montalcini R., Hamburger V. A nerve growth-stimulating factor isolated from sarcoma AS 37 and 180. Proceedings of the National Academy of Sciences of the United States of America 1954, 40:1014-1018.
2. Savage C.R., Hash J.H., Cohen S. Epidermal growth factor. Location of disulfide bonds. Journal of Biological Chemistry 1973, 248:7669-7672.
3. Savage C.R., Inagami T., Cohen S. The primary structure of epidermal growth factor. Journal of Biological Chemistry 1972, 247:7612-7621.
4. Brown J.P., Twardzik D.R., Marquardt H., Todaro G.J. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature 1985, 313:491-492.
5. Gray A., Dull T.J., Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 1983, 303:722-725.
6. Klapper L.N., Glathe S., Vaisman N., Hynes N.E., Andrews G.C., Sela M., et al. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:4995-5000.
7. Todaro G.J., De Larco J.E., Cohen S. Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 1976, 264:26-31.
8. Roberts A.B., Anzano M.A., Lamb L.C., Smith J.M., Frolik C.A., Marquardt H., et al. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature 1982, 295:417-419.
9. Sporn M.B., Todaro G.J. Autocrine secretion and malignant transformation of cells. New England Journal of Medicine 1980, 303:878-880.
10. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nature Reviews Molecular Cell Biology 2001, 2:127-137.
11. Burgess A.W. EGFR family: structure physiology signalling and therapeutic targets. Growth Factors 2008, 26:263-274.
12. Zhang X., Gureasko J., Shen K., Cole P.A., Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006, 125:1137-1149.
13. Hynes N.E., MacDonald G. ErbB receptors and signaling pathways in cancer. Current Opinion in Cell Biology 2009, 21:177-184.
14. Wada T., Qian X.L., Greene M.I. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 1990, 61:1339-1347.
15. Goldman R., Levy R.B., Peles E., Yarden Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 1990, 29:11024-11028.
16. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
17. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:13306-13311.
18. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
19. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine 2004, 350:2129-2139.
20. Schneider M.R., Wolf E. The epidermal growth factor receptor ligands at a glance. Journal of Cellular Physiology 2008, 218:460-466.
21. Strachan L., Murison J.G., Prestidge R.L., Sleeman M.A., Watson J.D., Kumble K.D. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. Journal of Biological Chemistry 2001, 276:18265-18271.
22. Kochupurakkal B.S., Harari D., Di-Segni A., Maik-Rachline G., Lyass L., Gur G., et al. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. Journal of Biological Chemistry 2005, 280:8503-8512.
23. Tzahar E., Moyer J.D., Waterman H., Barbacci E.G., Bao J., Levkowitz G., et al. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO Journal 1998, 17:5948-5963.
24. Shoyab M., Plowman G.D., McDonald V.L., Bradley J.G., Todaro G.J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989, 243:1074-1076.
25. Pathak B.G., Gilbert D.J., Harrison C.A., Luetteke N.C., Chen X., Klagsbrun M., et al. Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (Btc), and heparin-binding EGF (Hegfl). Genomics 1995, 28:116-118.
26. Sahin U., Blobel C.P. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Letters 2007, 581:41-44.
27. Shelly M., Pinkas-Kramarski R., Guarino B.C., Waterman H., Wang L.M., Lyass L., et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. Journal of Biological Chemistry 1998, 273:10496-10505.
28. Ebner R., Derynck R. Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regulation 1991, 2:599-612.
29. Reddy C.C., Niyogi S.K., Wells A., Wiley H.S., Lauffenburger D.A. Engineering epidermal growth factor for enhanced mitogenic potency. Nature Biotechnology 1996, 14:1696-1699.
30. South J.C., Blackburn E., Brown I.R., Gullick W.J. The neuregulin system of ligands and their receptors in rat islets of langerhans. Endocrinology 2013, 154:2385-2392.
31. Amsellem-Ouazana D., Bieche I., Tozlu S., Botto H., Debre B., Lidereau R. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder. Journal of Urology 2006, 175:1127-1132.
32. McIntyre E., Blackburn E., Brown P.J., Johnson C.G., Gullick W.J. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. Breast Cancer Research and Treatment 2010, 122:105-110.
33. Oshima G., Wennerberg J., Yamatodani T., Kjellen E., Mineta H., Johnsson A., et al. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines. Journal of Cancer Research and Clinical Oncology 2012, 138:491-499.
34. Byer S.J., Brossier N.M., Peavler L.T., Eckert J.M., Watkins S., Roth K.A., et al. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands. Journal of Neuropathology and Experimental Neurology 2013, 72:219-233.
35. Lefebvre S., Fliniaux I., Schneider P., Mikkola M.L. Identification of ectodysplasin target genes reveals the involvement of chemokines in hair development. Journal of Investigative Dermatology 2012, 132:1094-1102.
36. Voutilainen M., Lindfors P.H., Lefebvre S., Ahtiainen L., Fliniaux I., Rysti E., et al. Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-kappaB. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:5744-5749.
37. Lin M.H., Chang K.W., Lin S.C., Miner J.H. Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling. Developmental Biology 2010, 344:707-719.
38. Maier H., Meixner M., Hartmann D., Sandhoff R., Wang-Eckhardt L., Zoller I., et al. Normal fur development and sebum production depends on fatty acid 2-hydroxylase expression in sebaceous glands. Journal of Biological Chemistry 2011, 286:25922-25934.
39. Carletti M.Z., Christenson L.K. Rapid effects of LH on gene expression in the mural granulosa cells of mouse periovulatory follicles. Reproduction 2009, 137:843-855.
40. Taniguchi K., Yamamoto S., Aoki S., Toda S., Izuhara K., Hamasaki Y. Epigen is induced during the interleukin-13-stimulated cell proliferation in murine primary airway epithelial cells. Experimental Lung Research 2011, 37:461-470.
41. Dahlhoff M., Schafer M., Wolf E., Schneider M.R. Genetic deletion of the EGFR ligand epigen does not affect mouse embryonic development and tissue homeostasis. Experimental Cell Research 2013, 319:529-535.
42. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750.
43. Hinkle C.L., Sunnarborg S.W., Loiselle D., Parker C.E., Stevenson M., Russell W.E., et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. Journal of Biological Chemistry 2004, 279:24179-24188.
44. Mitchell C., Nivison M., Jackson L.F., Fox R., Lee D.C., Campbell J.S., et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. Journal of Biological Chemistry 2005, 280:2562-2568.
45. Zhou Y., Lee J.Y., Lee C.M., Cho W.K., Kang M.J., Koff J.L., et al. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-beta-induced pulmonary fibrosis. Journal of Biological Chemistry 2012, 287:41991-42000.